OK, there seems to have been a few reasonable objections. The consensus seems to be we will wait until the end of the year. I think from then on we will change over for biojava-live.
There was a suggestion of maintaining two branches, one would be a maintenance of biojava1.4 and only use JDK1.4.2, the other would be biojava-live and use JDK1.5. I have done this in the past and have no desire to do it again, it's really not that much fun. I would however like to reserve the option of putting JDK1.5 dependent code into the classes of the org.biojavax package. If this happens I will adjust the ANT build script such that these are not compiled if JDK1.5 is not detected. This should be safe as the biojava packages have no dependencies on the biojavax packages. Bug fixes to biojava would still be in the system. Additionally the org.biojavax packages are undergoing a lot of development right now so you shouldn't be doing any production programming with them anyway. - Mark Mark Schreiber Principal Scientist (Bioinformatics) Novartis Institute for Tropical Diseases (NITD) 10 Biopolis Road #05-01 Chromos Singapore 138670 www.nitd.novartis.com phone +65 6722 2973 fax +65 6722 2910 _______________________________________________ Biojava-l mailing list - Biojava-l@biojava.org http://biojava.org/mailman/listinfo/biojava-l
